金沙集團 LVS 深 滬
等待開盤 01-10 09:30:00 美东时间
58.95
-2.950
-4.77%
華盛通- 最 高62.11
- 今 開62.11
- 成交量 977.47万股
- 最 低 58.865
- 昨 收 61.90
- 總市值 404.40亿
- 52周最高 70.4545
- 市盈率 靜 30.05
- 換手率 1.42%
- 52周最低 29.43
- 委 比 16.74%
- 總股本 6.86亿
- 歷史最高 73.42
- 量 比 1.72
- 振 幅 5.24%
- 歷史最低 16.25
- 每 手 1
- 風險率 9.98%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Goldman’s best fundamental ideas with upside to estimates on upcoming earnings season
Goldman Sachs Research has identified its top fundamental opportunities with expected upside from estimates, highlighting stocks where analysts see significant upside to consensus estimates heading in...
01-09 02:47
Super Group is the best performing casino stock year-to-date
The S&P 500 consumer discretionary sector has struggled to keep pace with the broader market in 2025, gaining +7.2% year-to-date, falling short of the S&P 500’s (SP500) overall performance. The secto...
2025-12-20 01:05
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
高盛上调金沙集团与万豪股票评级
美股周一早盘，拉斯维加斯金沙集团（Las Vegas Sands）股价上涨2.6%，万豪国际（Marriott International）上涨2.2%，此...
2025-12-15 22:51
Goldman Sachs Upgrades Las Vegas Sands to Buy, Raises Price Target to $80
Goldman Sachs analyst Lizzie Dove upgrades Las Vegas Sands (NYSE:LVS) from Neutral to Buy and raises the price target from $64 to $80.
2025-12-15 20:14
Stock index futures rebound to kick off busy economic week
Stock index futures pointed to a higher open Monday following selling in the previous session. S&P 500 futures (SPX) were up +0.57%, Nasdaq 100 futures (US100:IND) increased by +0.55%, and Dow Jones I...
2025-12-15 19:22
Looking Into Las Vegas Sands Corp's Recent Short Interest
Las Vegas Sands Corp's (NYSE:LVS) short interest as a percent of float has rise...
2025-12-09 04:00
美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
2025-12-02 09:50
Argus Research Maintains Buy on Las Vegas Sands, Raises Price Target to $80
Argus Research analyst John Staszak maintains Las Vegas Sands (NYSE:LVS) with a Buy and raises the price target from $65 to $80.
2025-12-01 21:38
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
2025-11-19 11:01
